Clinical Trials Directory

Trials / Sponsors / Kaken Pharmaceutical

Kaken Pharmaceutical

Industry · 10 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Study to Investigate Efficacy and Safety of KP-001 Compared With Placebo in Patients Aged ≥2 Years With Comm
Venous Malformations, Lymphatic Malformations, Klippel-Trenaunay Syndrome
Phase 32026-02-26
CompletedTo Determine the Effect of KP-001 on Rosuvastatin, Caffeine PK and the Effect of Fluvoxamine on KP-001 PK in V
Healty Volunteers
Phase 12025-02-13
CompletedA Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of KP-001
Healthy Adults, Hepatic Impairment
Phase 12024-10-24
CompletedA Study to Evaluate the Effects of KP-001 on the QT/QTc Intervals in Healthy Adults
Healthy Volunteers - Male and Female
Phase 12024-10-01
CompletedA Study to Determine the Effect of KP-001 on Metformin and Midazolam Pharmacokinetics and the Effect of Clarit
Healthy Adults
Phase 12023-12-15
CompletedA Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3)
Periodontitis
Phase 32009-11-01
CompletedA Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)
Atopic Dermatitis
Phase 1 / Phase 22009-07-01
CompletedPhase 3 Clinical Trial of Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2(Trafermin)
Periodontitis, Alveolar Bone Loss, Periodontal Attachment Loss
Phase 32008-08-01
CompletedA Phase2 Clinical Trial of Trafermin in Patients With Marginal Periodontitis in Japan
Periodontitis
Phase 22005-08-01
CompletedTrial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2
Periodontitis
Phase 22001-12-01